Interleukin-18 gene promoter and serum level in women with ovarian cancer

Molecular Biology Reports

Volumn 36, Issue 8, 2009, Pages 2393-2397

  Samsami Dehaghani, Alamtaj ^a   Shahriary, Khatere ^a   Kashef, Mohammad Amin ^b   Naeimi, Sirous ^b   Fattahi, Mohammad Javad ^b   Mojtahedi, Zahra ^b   Ghaderi, Abbas ^a,b  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Gene; IL 18; Ovarian cancer; Promoter

Indexed keywords

INTERLEUKIN 18;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; CANCER GROWTH; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; OVARY CANCER; POLYMERASE CHAIN REACTION; PROMOTER REGION; PROTEIN BLOOD LEVEL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERLEUKIN-18; MIDDLE AGED; OVARIAN NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC;

EID: 70350338752     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-009-9469-7     Document Type: Article

References (24)

1. DM Parkin F Bray J Ferlay, et al. 2001 Estimating the world cancer burden: globocan 2000 Int J Cancer 94 153 156 10.1002/ijc.1440 10.1002/ijc.1440 1:CAS:528:DC%2BD3MXntVGlu78%3D 11668491 (Pubitemid 32911406)
2. RB Ness JA Grisso C cottreau, et al. 2000 Factors related to inflammation of the ovarian epithelium and risk of ovarian cancer Epidemiology 11 111 117 10.1097/00001648-200003000-00006 10.1097/00001648-200003000-00006 1:STN:280:DC%2BD3cvmsFKkuw%3D%3D 11021606 (Pubitemid 30112009)
3. AW Bushley R Ferrell K McDuffie, et al. 2004 Polymorphisms of interleukin (IL)-1alpha, IL-1beta, IL-6, IL-10, and IL-18 and the risk of ovarian cancer Gynecol Oncol 95 672 679 10.1016/j.ygyno.2004.08.024 10.1016/j.ygyno.2004.08.024 1:CAS:528:DC%2BD2cXhtVCgu7jF 15581980 (Pubitemid 39592536)
4. BB Aggarwal S Shishodia SK Sandur, et al. 2006 Inflammation and cancer: how hot is the link? Biochem Pharmacol 72 1605 1621 10.1016/j.bcp.2006.06.029 10.1016/j.bcp.2006.06.029 1:CAS:528:DC%2BD28XhtFOjt77E 16889756 (Pubitemid 44666739)
5. S Park S Cheon D Cho 2007 The dual effects of interleukin-18 in tumor progression Cell Mol Immunol 4 329 335 1:CAS:528:DC%2BD2sXhsVeks7vJ 17976312
6. T Khalili-Azad M Razmkhah AF Ghiam, et al. 2009 Association of Interleukin-18 gene promoter polymorphisms with breast cancer Neoplasma 56 20 23 10.4149/neo-2009-01-22
7. K Nakanishi T Yoshimoto H Tsutsui, et al. 2001 Interleukin-18 is a unique cytokine that stimulates both Th1 and Th2 responses depending on its cytokine milieu Cytokine Growth Factor Rev 12 53 72 10.1016/S1359-6101(00)00015-0 10.1016/S1359-6101(00)00015-0 1:CAS:528:DC%2BD3MXjtFOhsbY%3D 11312119 (Pubitemid 32294587)
8. F Vidal-Vanaclocha L Mendoza N Telleria, et al. 2006 Clinical and experimental approaches to the pathophysiology of interleukin-18 in cancer progression Cancer Metastasis Rev 25 417 434 10.1007/s10555-006-9013-3 10.1007/s10555-006-9013-3 1:CAS:528:DC%2BD28Xht1yktb3P 17001512 (Pubitemid 44922359)
9. SR Bornstein H Rutkowski I Vrezas SR Bornstein, et al. 2004 Cytokines and steroidogenesis Mol Cell Endocrinol 215 135 141 10.1016/j.mce.2003.11.022 10.1016/j.mce.2003.11.022 1:CAS:528:DC%2BD2cXitFCgsrc%3D 15026186 (Pubitemid 38333252)
10. A Gaggero A De Ambrosis D Mezzanzanica, et al. 2004 A novel isoform of pro-interleukin-18 expressed in ovarian tumors is resistant to caspase-1 and -4 processing Oncogene 23 7552 7560 10.1038/sj.onc.1208036 10.1038/sj.onc.1208036 1:CAS:528:DC%2BD2cXnvFGkurg%3D 15326478 (Pubitemid 39389697)
11. J Akahiro R Konno K Ito K Okamura, et al. 2004 Impact of serum interleukin-18 level as a prognostic indicator in patients with epithelial ovarian carcinoma Int J Clin Oncol 9 42 46 10.1007/s10147-003-0360-6 10.1007/s10147-003-0360-6 15162825 (Pubitemid 38470662)
12. C Le Page V Ouellet J Madore, et al. 2006 From gene profiling to diagnostic markers: IL-18 and FGF-2 complement CA125 as serum-based markers in epithelial ovarian cancer Int J Cancer 118 1750 1758 10.1002/ijc.21521 10.1002/ijc.21521 1:CAS:528:DC%2BD28XislKlsL8%3D 16217764 (Pubitemid 43376439)
13. N Gunel U Coskun B Sancak, et al. 2002 Clinical importance of serum interleukin-18 and nitric oxide activities in breast carcinoma patients Cancer 95 663 667 10.1002/cncr.10705 10.1002/cncr.10705 1:CAS:528:DC%2BD38XmsVWqsr0%3D 12209760 (Pubitemid 34810193)
14. K Tsuboi T Miyazaki M Nakajima, et al. 2004 Serum interleukin-12 and interleukin-18 levels as a tumor marker in patients with esophageal carcinoma Cancer Lett 205 207 214 10.1016/j.canlet.2003.10.010 10.1016/j.canlet.2003.10. 010 1:CAS:528:DC%2BD2cXhsVKitLY%3D 15036653 (Pubitemid 38230128)
15. T Kawabata T Ichikura T Majima, et al. 2001 Preoperative serum interleukin-18 level as a postoperative prognostic marker in patients with gastric carcinoma Cancer 92 2050 2055 10.1002/1097-0142(20011015)92:8<2050:: AID-CNCR1544>3.0.CO;2-5 10.1002/1097-0142(20011015)92:8<2050::AID- CNCR1544>3.0.CO;2-5 1:STN:280:DC%2BD3MrkvVKnsg%3D%3D 11596019 (Pubitemid 32973313)
16. A Jebreel D Mistry D Loke, et al. 2007 Investigation of interleukin 10, 12 and 18 levels in patients with head and neck cancer J Laryngol Otol 121 246 252 10.1017/S0022215106002428 10.1017/S0022215106002428 1:STN:280: DC%2BD2s7jslGmtw%3D%3D 17040593 (Pubitemid 46833125)
17. V Giedraitis B He WX Huang, et al. 2001 Cloning and mutation analysis of the human IL-18 promoter: a possible role of polymorphisms in expression regulation J Neuroimmunol 112 146 152 10.1016/S0165-5728(00)00407-0 10.1016/S0165-5728(00)00407-0 1:CAS:528:DC%2BD3cXosFeqsbc%3D 11108943
18. J Bai Y Zhang M Lin, et al. 2007 Interleukin-18 gene polymorphisms and haplotypes in patients with oral lichen planus: a study in an ethnic Chinese cohort Tissue Antigens 70 390 397 10.1111/j.1399-0039.2007.00922.x 10.1111/j.1399-0039.2007.00922.x 1:CAS:528:DC%2BD2sXhtlaktr%2FI 17854431 (Pubitemid 47537401)
19. Y Liu N Lin L Huang, et al. 2007 Genetic polymorphisms of the interleukin-18 gene and risk of prostate cancer DNA Cell Biol 26 613 618 10.1089/dna.2007.0600 10.1089/dna.2007.0600 1:CAS:528:DC%2BD2sXoslags7Y%3D 17688413 (Pubitemid 47263208)
20. YS Wei Y Lan YG Liu, et al. 2007 Interleukin-18 gene promoter polymorphisms and the risk of esophageal squamous cell carcinoma Acta Oncol 46 1090 1096 10.1080/02841860701373595 10.1080/02841860701373595 1:CAS:528:DC%2BD2sXht1GrsrbO 17851835 (Pubitemid 350058881)
21. V Asefi Z Mojtahedi B Khademi, et al. 2008 Head and neck squamous cell carcinoma is not associated with interleukin-18 promoter gene polymorphisms: a case-control study J Laryngol Otol 10.1017/S0022215108003733 18940019
22. SA Miller DD Dykes HF Polesky 1988 A simple salting out procedure for extracting DNA from human nucleated cells Nucleic Acids Res 16 1215 10.1093/nar/16.3.1215 10.1093/nar/16.3.1215 1:CAS:528:DyaL1cXhsVKlsrs%3D 3344216
23. T Osaki JM Péron Q Cai, et al. 1998 IFN-gamma-inducing factor/IL-18 administration mediates IFN-gamma- and IL-12-independent antitumor effects J Immunol 160 1742 1749 1:CAS:528:DyaK1cXhtVyksLo%3D 9469432
24. H Park D Byun TS Kim, et al. 2001 Enhanced IL-18 expression in common skin tumors Immunol Lett 79 215 219 10.1016/S0165-2478(01)00278-4 10.1016/S0165-2478(01)00278-4 1:CAS:528:DC%2BD3MXnsVSnsbo%3D 11600201 (Pubitemid 32971896)